» Authors » C Hallie Phillips

C Hallie Phillips

Explore the profile of C Hallie Phillips including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 243
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung J, Price A, Zimmerman R, Moehling Geffel K, House S, Curley T, et al.
Clin Infect Dis . 2025 Jan; PMID: 39761230
Background: The 2023-24 U.S. influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with co-circulation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United...
2.
Hughes Kramer K, Zimmerman R, Haggerty C, Balasubramani G, Nowalk M, Martin E, et al.
Hum Vaccin Immunother . 2024 Dec; 20(1):2354013. PMID: 39693194
While the number of immunocompromised (IC) individuals continues to rise, the existing literature on influenza vaccine effectiveness (VE) in IC populations is limited. Understanding the vaccine effectiveness (VE) of the...
3.
Chung J, Price A, Zimmerman R, Moehling Geffel K, House S, Curley T, et al.
medRxiv . 2024 Nov; PMID: 39574872
Background: The 2023-24 U.S. influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with co-circulation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United...
4.
King J, Nguyen H, Kiniry E, Phillips C, Gaglani M, Martin E, et al.
Sci Rep . 2024 Sep; 14(1):21466. PMID: 39271784
Elevated body mass index (BMI) has been linked to severe influenza illness and impaired vaccine immunogenicity, but the relationship between BMI and clinical vaccine effectiveness (VE) is less well described....
5.
Ahmed F, Nowalk M, Zimmerman R, Bear T, Grijalva C, Talbot H, et al.
Emerg Infect Dis . 2023 Nov; 29(12):2442-2450. PMID: 37917142
Both SARS-CoV-2 and influenza virus can be transmitted by asymptomatic, presymptomatic, or symptomatic infected persons. We assessed effects on work attendance while ill before and during the COVID-19 pandemic in...
6.
Price A, Flannery B, Talbot H, Grijalva C, Wernli K, Phillips C, et al.
Clin Infect Dis . 2022 Dec; 76(8):1358-1363. PMID: 36504336
Background: In the United States, influenza activity during the 2021-2022 season was modest and sufficient enough to estimate influenza vaccine effectiveness (VE) for the first time since the beginning of...
7.
Jackson M, Phillips C, Wellwood S, Kiniry E, Jackson L, Martin E, et al.
Vaccine . 2022 Nov; 40(52):7703-7708. PMID: 36379754
Background: Epidemics of seasonal influenza vary in intensity annually, and influenza vaccine effectiveness (VE) fluctuates based in part on antigenic match to circulating viruses. We estimated the incidence of influenza...
8.
Chung J, Kim S, Kondor R, Smith C, Budd A, Tartof S, et al.
MMWR Morb Mortal Wkly Rep . 2022 Mar; 71(10):365-370. PMID: 35271561
In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months except when contraindicated (1). Currently available influenza vaccines are designed to protect against...
9.
Jackson M, Starita L, Kiniry E, Phillips C, Wellwood S, Cho S, et al.
Clin Infect Dis . 2021 Feb; 73(5):802-807. PMID: 33590002
Background: Although multiple respiratory viruses circulate in humans, few studies have compared the incidence of different viruses across the life course. We estimated the incidence of outpatient illness due to...
10.
Jackson M, Phillips C, Benoit J, Kiniry E, Madziwa L, Nelson J, et al.
Vaccine . 2017 Dec; 36(5):751-757. PMID: 29254838
Introduction: Estimates of vaccine effectiveness (VE) from test-negative studies may be subject to selection bias. In the context of influenza VE, we used simulations to identify situations in which meaningful...